Filing Details
- Accession Number:
- 0001179110-11-006920
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-26 21:44:19
- Reporting Period:
- 2011-04-20
- Filing Date:
- 2011-04-26
- Accepted Time:
- 2011-04-26 21:44:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1157601 | Synta Pharmaceuticals Corp | SNTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1325718 | Keizo Koya | C/O Synta Pharmaceuticals Corp. 45 Hartwell Avenue Lexington MA 02421 | Sr. Vp, Drug Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-04-20 | 10,000 | $5.60 | 29,843 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-04-25 | 10,000 | $6.00 | 19,843 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2010.
Billionaire Hedge Funds
